Get started

Covidplay

Columbia Pattern ConfirmationThe TA should speak for itself. The current uptrend for COLM shows a continuation of the bullish recovery for this stock. In addition, look at the macro-economic environment. With impending social restrictions caused by Covid-19s resurgence across the USA, and temperatures dropping, this is the logical time to invest in Winter Outerwear. Local businesses and public spaces will be closed soon, but that only pertains to indoor gatherings. As a result, people will flock to the outdoor patios and seating to comply with government regulations. VFC, which owns "The North Face" is also a suitable play given this development, but Columbia's technical indicators and pattern make this stock more enticing. In summation: Fed QE + Winter + Covid-19 + Indoor Gathering restrictions = COLM LONG Personal Opinion & TA interpretation, not investment advice* Best of Luck!
NASDAQ:COLMLong
by kingmidasLXIX
2
HUGE -- Oversold COVID-19 play; insiders buying at premiumI am in at $2.35. - Oversold, RSI @ 21 - $9.5 USD financing just closed at $3.10 CDN with insiders/institutions buying ahead of COVID-19 treatment Phase 2 trial results - Will need to maintain $4+ stock price to stay listed on NASDAQ - Gaps above at 3.33 & 5.56 - Signs of bottoming out - $25M in cash; with Cannabis asset sale (~$20M), the cash position will exceed market cap - Due for COVID-19 treatment Phase 2 trial results within a week or two
HLong
by wealth_bakery
2
Covid US Deaths Technical Analysisidentifying patterns. can see how the mac D on total us deaths is starting to turn bearish, i can see a slowdown happen around election day @ 225000 deaths could peak a few months past into new years @ 285000 deaths before really starting to flatline the squeeze indicator is also showing slowdown in confirmed deaths. we are hitting the top of the ascending wedge, (bearish) the MACD and RSI are both turning bearish as well election and newyears big things are to come. the virus is slowing down as the data shows. I dont care what the news say theres tons of other charts, like confirmed cases and such, but I just like confirmed deaths since the case numbers are not as accurate.
D
by ToddGreen
Rapid Recovery Respiratory Failure - COVID-19 TreatmentRelief Therapeutics Holding AG, a clinical stage biotechnology company, engages in developing treatment solutions for indications related to diabetic complications and respiratory diseases. The company is developing aviptadil, which has completed Phase II clinical trial for the treatment of sarcoidosis, an orphan pulmonary disease, as well as pulmonary hypertension; and atexakin alfa that has completed Phase I clinical trial to treat peripheral diabetic neuropathy. Relief Therapeutics Holding AG is based in Geneva, Switzerland. RLF-100 (aviptadil) clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication in human lung cells - Rapid recovery of patients on ventilators and ECMO (extracorporeal membrane oxygenation) was seen in patients with severe medical comorbidities after three days of treatment with RLF-100 under FDA Emergency Use IND authorization at multiple clinical sites - Aviptadil is being developed as the first COVID therapeutic to block replication of the SARS-CoV-2 virus in human lung cells and monocytes - RLF-100 is a patented formulation of aviptadil (synthetic human Vasoactive Intestinal Polypeptide VIP), which has been granted FDA Fast Track Designation, FDA emergency use IND authorization, and an expanded access protocol finance.yahoo.com I think this stock could spike like Moderna Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
OTC:RLFTFLong
by HotCharts
1